170262 ⎘
Assays involving biological materials from specific organisms or of a specific nature from viruses; RNA viruses; Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus; Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV; HIV-1, HIV-2 Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx
EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#2Compounds inhibiting Nef-calnexin interaction
#3Compounds inhibiting Nef-calnexin interaction
#4CAMPTOTHECIN DERIVATIVES AS ANTI-HIV AGENTS AND METHODS OF IDENTIFYING AGENTS THAT DISRUPT VIF SELF-ASSOCIATION
#5Exosome-mediated diagnosis of human immunodeficiency virus infection
#6Exosome-mediated diagnosis of hepatitis virus infections and diseases
#7Compounds inhibiting Nef-calnexin interaction
#8Silica-based biomolecule carrier, pharmaceutical composition comprising the same, preparation method and use thereof
#9EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#10Exosome-mediated diagnosis of hepatitis virus infections and diseases
#11Exosome-mediated diagnosis of hepatitis virus infections and diseases
#12Camptothecin derivatives as anti-HIV agents and methods of identifying agents that disrupt Vif self-association
#13SMALL MOLECULES AS ANTI-HIV AGENTS THAT DISRUPT VIF SELF-ASSOCIATION AND METHODS OF USE THEREOF
#14Assay for Screening of Anti-Viral Compounds That Inhibit Specific Interaction Interfaces Between Cullin5 and an ElonginB/ElonginC/ CBF-beta/HIV-1 Vif Complex
#15Dual inducible vectors and cell lines
#16Exosome-mediated diagnosis of hepatitis virus infections and diseases
#17Vector, vector combinations, methods and kit thereof
#18Detection of HIV-related proteins in urine
#19Detection of HIV-related proteins in urine
#20Compositions and Methods for Modulating Immunodeficiency Virus Transcription
#21OVERLAPPING PEPTIDES FROM VARIABLE ANTIGENS, T CELL POPULATIONS AND USES THEREOF
#22Nucleic acid ligand complexes
#23TAT-BASED IMMUNOMODULATORY COMPOSITIONS AND METHODS FOR THEIR DISCOVERY AND USE
#24Compounds that Inhibit HIV Particle Formation
#25METHOD FOR DETERMINING ONE OF THE TWO HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTEGRASE ENZYMATIC ACTIVITIES
#26Detection of HIV-related proteins in urine
#27High Affinity Nucleic Acid Ligands To Lectins
#28TREATMENT OF HIV-1 BY MODULATION OF VPR ACTIVATION OF THE M-CSF PROMOTER
#29Compounds that inhibit HIV particle formation
#30Monoclonal antibodies to HIV-1 and methods of using same
#31METAL BINDING PROTEINS AND ASSOCIATED METHODS
#32Mutated HIV Nef for modulating immunity
#33Tat-based immunomodulatory compositions and methods of their discovery and use
#34Hiv-dependent expression constructs and uses therefor
#35Metal binding proteins and associated methods
#36HUMAN IMMUNODEFICIENCY VIRUS ENTRY INHIBITOR ASSAY
#37Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
#38Method for monitoring anti-HIV treatment in HIV infected individuals
#39P38 kinase inhibitor compositions and methods of using the same
#40Tenascin-C nucleic acid ligands
#41Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
#42High affinity TGFbeta nucleic acid ligands and inhibitors
#43Werner's syndrome helicase as a target for anti -HIV/AIDS therapy
#44Screening methods for the identification of inhibitors of human immunodeficiency virus (HIV) viral protein R (Vpr) binding to the adenine nucleotide translocator (ANT)
#45Methods and compositions for impairing multiplication of HIV-1
#46Inhibition of viral maturation, methods and compositions related thereto
#47Tat-based immunomodulatory compositions and methods for their discovery and use
#48Nucleic acid ligand complexes
#49Truncation SELEX method
#50Inhibition of retroviral replication through modulation of the host cell ubiquitylation
#51High affinity RNA ligands of basic fibroblast growth factor
#52HIV-1 VPR interactions with mitochondrial apoptosis inducing factor and methods of using the same